ArticleCancer drug resistance (Alhambra, Calif.)2022

Tackling heterogeneity in treatment-resistant breast cancer using a broad-spectrum therapeutic approach.

Leroy Lowe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.